Skip to content

Telehealth Diabetes Prevention Intervention for African American Youth

A Telehealth Diabetes Prevention Intervention for the Next Generation of African American Youth (TELE-GEN) Pilot Study

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04618458
Acronym
TELE-GEN
Enrollment
38
Registered
2020-11-06
Start date
2020-12-01
Completion date
2021-12-18
Last updated
2022-08-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obesity, Obesity, Childhood, PreDiabetes

Keywords

prediabetic state, telehealth, healthy lifestyle, primary prevention, minority health

Brief summary

The Telehealth Diabetes Prevention Intervention for the Next Generation of African American Youth (TELE-GEN) pilot study will evaluate the implementation and early efficacy of a telehealth diabetes prevention intervention for African American (AA) children (8- to 11-years) and their parents. Power to Prevent is a lifestyle diabetes prevention intervention from the Centers for Disease Control and Prevention that is based on the Diabetes Prevention Program and tailored for AA families. To investigators knowledge, this intervention has not been evaluated in a clinical trial with AA families with children at risk for type 2 diabetes mellitus (T2DM), nor been delivered via telehealth. Employing an effectiveness-implementation hybrid study design, investigators aim to concurrently (1) conduct a single arm pilot trial to assess the early efficacy of Power to Prevent delivered via telehealth to treat overweight/obesity in AA children and their parent, while (2) evaluating an implementation strategy for the uptake of the intervention by the pediatric weight management clinic at the University of Mississippi Medical Center. The primary outcome will be stabilization or reduction in BMI z-score in children (index participant) and reduction in parent BMI (co-participant). Parents (n=20) will receive the same telehealth diabetes prevention intervention, which will be delivered by a racially concordant, trained Lifestyle Coach using small-group videoconferencing (5 parents per group). Sessions will consist of nutrition and physical activity behavior change strategies (20 min), problem solving and decision-making skills to circumvent barriers to behavioral change (20 min), and family goal setting and action planning (20 min). Child and parent measures will be assessed at baseline, 12-weeks (post-intervention), and 30-weeks (follow-up). The implementation strategy has two targets: (1) the pediatric weight management clinical and clinical care team; and (2) overweight/obese pediatric patients and their overweight/obese parents. The multifaceted implementation plan includes four discrete strategies: (1) creating a new clinical team; (2) changing the service site; (3) intervening with families; and (4) assessing organizational readiness. Preliminary findings will provide data to design a full-scale study that will include a powered pilot randomized controlled trial to test the interventions effectiveness for preventing T2DM, while evaluating a refined implementation protocol.

Detailed description

The Telehealth Diabetes Prevention Intervention for the Next Generation of African American Youth (TELE-GEN) pilot study will evaluate the implementation and early efficacy of a telehealth diabetes prevention intervention for African American (AA) children (8- to 11-years-old) and their parents. Power to Prevent is a lifestyle diabetes prevention intervention from the Centers for Disease Control and Prevention that is based on the Diabetes Prevention Program (DPP) and tailored specifically for AA families. To the knowledge of the study's investigators, this intervention has not yet been evaluated in a clinical trial with AA families with children at risk for T2DM, nor been delivered via telehealth. Employing an effectiveness-implementation hybrid research design, investigators aim to concurrently: (1) conduct a single arm pilot clinical trial to assess the early efficacy of Power to Prevent delivered via telehealth to treat overweight/obesity in AA children and their parent, while (2) comprehensively evaluate a multifaceted implementation strategy for the uptake of Power to Prevent delivered via telehealth by UMMC's pediatric weight management clinic. The primary outcome measure will be stabilization or reduction in BMI z-score in children (index participant) and a reduction in parent BMI (co-participant). Eligible overweight/obese children and their overweight/obese parent (N=20 families) will receive the same telehealth diabetes prevention intervention based on Power to Prevent, which will be delivered by a racially concordant Lifestyle Coach trained in the DPP. Families will meet weekly for 11-weeks (60-min sessions), and then monthly (60-min sessions) for 4 pilot behavioral reinforcement maintenance sessions (15 sessions total). Participants will meet in their respective groups (n=5 families per group) via videoconferencing using Wi-Fi-enabled tablets with cellular connectivity for the entire intervention. Sessions will consist of nutrition and physical activity behavior change strategies (20 min), problem solving and decision-making skills to circumvent barriers to behavioral change (20 min), and family goal setting and action planning (20 min). Assessment measures will be collected from the child and parent participants at baseline, 12-weeks (post-intervention), and 30-weeks (follow-up). The implementation strategy has two targets: (1) UMMC's pediatric weight management clinical setting and clinical care team; and (2) overweight/obese pediatric patients and their overweight/obese parents referred to and engaged in intensive obesity treatment for the prevention of T2DM. The multifaceted implementation plan includes four discrete strategies: (1) creating a new clinical team; (2) changing the service site; (3) intervening with families; and (4) assessing organizational readiness. Preliminary findings will provide sufficient data to design a full-scale effectiveness-implementation hybrid study that will include a powered pilot randomized controlled trial (RCT) to test the interventions effectiveness for preventing T2DM, while evaluating a refined implementation protocol. The overall purpose of the TELE-GEN pilot study directly contributes to the goal of the Jackson Heart Study Community Engagement Center by leveraging existing infrastructure and technology to engage AA families in a virtual community to prevent T2DM. The proposed aims and methods also parallel the NHLBI's strategic goal to advance transnational research.

Interventions

BEHAVIORALPower to Prevent

Lifestyle diabetes prevention intervention based on the National Diabetes Prevention Program and tailored for African American families. The intervention will be delivered using telehealth and small group videoconferencing.

Sponsors

University of Mississippi Medical Center
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
8 Years to 11 Years
Healthy volunteers
No

Inclusion criteria

* AA parents (biological, grandparent, legal guardian) and their 8- to 11-year-old child residing in the same home. * One overweight/obese parent (BMI ≥25 kg/m2) and child (≥ 85th% age-/sex-specific BMI). * Parent at-risk for diabetes (American Diabetes Association risk test) AND HbA1c 5.7% - 6.4%.

Exclusion criteria

* child or parent has a history of T2DM or a screening HbA1c \>6.4%; * is taking glucose-lowering medications; * is participating in a supervised weight loss program; * is pregnant or breast feeding; * has conditions limiting participation; * has undergone weight loss surgery; * is moving out-of-state within 6 months. * If a parent becomes pregnant during the study, we will include only child data (index participant) in analyses

Design outcomes

Primary

MeasureTime frameDescription
Parent BMIChange from baseline parent BMI to 12-weeksStandard anthropometric procedures and a calibrated body weight scale will be used to measure participants' weight (0.1kg), stature (0.1 cm); after converting cm to m, BMI = kg/m2
Child BMI z-scoreChange from baseline child BMI z-score to 12-weeksStandard anthropometric procedures and a calibrated body weight scale (Seca 777 digital scale with stadiometer) will be used to measure participants' weight (0.1kg), stature (0.1 cm); child BMI percentile will be calculated using the statistic equations made available on the Centers for Disease Control and Prevention (CDC) website

Secondary

MeasureTime frameDescription
Child physical activityChange from baseline child physical activity to 12-weeksObjective assessment using ActiGraph GT9X Link Accelerometers; child and parent will wear accelerometer continuously for seven day period
Parent physical activityChange from baseline parent physical activity to 12-weeksObjective assessment using ActiGraph GT9X Link Accelerometers; child and parent will wear accelerometer continuously for seven day period
Child out-of-school sedentary timeChange from baseline in child out-of-school sedentary time to 12-weeksObjective assessment using ActiGraph GT9X Link Accelerometers; child and parent will wear accelerometer continuously for seven day period
Parent sedentary timeChange from baseline in parent sedentary time to 12-weeksObjective assessment using ActiGraph GT9X Link Accelerometers; child and parent will wear accelerometer continuously for seven day period
Child Hemoglobin A1cChange from baseline child Hemoglobin A1c to 12-weeksA1CNOW+ System for reliable point-of-care HbA1c measurement; non-fasting 5 μL blood
Parent Hemoglobin A1cChange from baseline parent Hemoglobin A1c to 12-weeksA1CNOW+ System for reliable point-of-care HbA1c measurement; non-fasting 5 μL blood
Parent waist circumferenceChange from baseline in parent waist circumference to 12-weeksA Seca 203 circumference measuring tape will be used to assess participants waist circumference.
Child systolic blood pressureChange from baseline child systolic blood pressure to 12-weeksWelch Allyn blood pressure unit following the American Heart Association guidelines for children.
Child diastolic blood pressureChange from baseline child diastolic blood pressure to 12-weeksWelch Allyn blood pressure unit following the American Heart Association guidelines for children.
Parent systolic blood pressureChange from baseline parent systolic blood pressure to 12-weeksWelch Allyn blood pressure unit following the American Heart Association guidelines for adults.
Parent diastolic blood pressureChange from baseline parent diastolic blood pressure to 12-weeksWelch Allyn blood pressure unit following the American Heart Association guidelines for adults.
Parent resting heart rateChange from baseline in parent resting heart rate to 12-weeksWelch Allyn blood pressure unit
Parent readiness to changeChange from baseline in parent readiness to change to 12-weeksAdapted from Rhee et al., a 6-item instrument to assess parents readiness and intentions to make dietary, physical activity and sedentary changes.
Parent self-efficacyChange from baseline in parent self-efficacy to 12-weeksValid and reliable (Norma et al., 2018) 14-item instrument to measure parent efficacy for influencing children's physical activity, sedentary behavior and dietary behavior using an 11-point Likert scale; 0-not confident, 10-absolutely confident.
Child self-efficacyChange from baseline in child self-efficacy to 12-weeksA 9-item valid and reliable instrument by Lassetter et al., 2014 asking children to report their confidence on a 3-point Likert scale for eating healthy and being physically active; 1 item added to assess efficacy for watching less than 2 hours of television (TV) every day.
Parent perceived family functioningChange from baseline in parent perceived family functioning to 12-weeksMcMaster Family Assessment Device; a valid and reliable 60-item instrument using a 4-point Likert scale; subscales include problem solving, communication, roles, affective responsiveness, affective involvement, behavior control, general functioning
Home physical activity and food environmentChange from baseline in parent perceived home physical activity and food environment to 12-weeksThe Home Environment Survey; valid and reliable instrument (Gattshall et al., 2008) to measure the physical and social environment for food and physical activity; modified to include the physical and social environment for TV time (sedentary behavior); modified to include 79-items total; Dimensions: physical activity availability and accessibility of physical activity equipment, technology and food (i.e. fruit and vegetables); parental role modeling of physical activity, sedentary behavior, and dietary behavior.
Parent stressChange from baseline in parent stress to 12-weeksPerceived Stress Scale; 10-items (Cohen, 1994)
Parent perceived child obesity-related behaviorChange from baseline in parent perceived child health behavior to 12-weeksChild Obesity Behavior Scale; adapted from Rhee et al., 2014; 20-items to measure food, physical activity and sedentary behavior quantity and frequency.
Child perceived obesity-related behaviorChange from baseline in child health behavior to 12-weeksHealthy Eating and Physical Activity Recall Questionnaire; 9-items (Lassettter et al., 2017); modified to include questions for sedentary environment; 5-items.
Neighborhood Perception SurveyChange from baseline in parent neighborhood perception to 12-weeksValid and reliable 31-item instrument used by Mujahod et al., 2007 to assess 7 dimensions of neighborhood: aesthetic quality, walking environment, availability of healthy foods, safety, violence, social cohesion, activities with neighbors.
Child stressChange from baseline in parent stress to 12-weeksPROMIS Pediatric Psychological and Physical Stress Scale; 19-items and 26-items (Bevans et al., 2018)
Child resting heart rateChange from baseline in child resting heart rate to 12-weeksWelch Allyn blood pressure unit
Child waist circumferenceChange from baseline in child waist circumference to 12-weeksA Seca 203 circumference measuring tape will be used to assess participants waist circumference.

Other

MeasureTime frameDescription
Child tanner stageChange from baseline in child tanner stage to 12-weeksA valid and reliable self-administered rating scale for pubertal development; 5-items. (Carskadon and Acebo, 1993)

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026